The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors

Acta Physiologica

Volumn 204, Issue 2, 2012, Pages 267-276

  Savinainen, J R ^a   Saario, S M ^a   Laitinen, J T ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

hydrolase domain; 2 AG hydrolase; ABHD12; ABHD6; Endocannabinoid; Monoacylglycerol lipase

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ABHD12 PROTEIN; ABHD6 PROTEIN; ACYLGLYCEROL LIPASE; CALCIUM ION; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; FATTY ACID AMIDASE; G PROTEIN COUPLED RECEPTOR; LIPOPROTEIN LIPASE; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 5; SERINE DEHYDRATASE; UNCLASSIFIED DRUG;

BRAIN CORTEX; BRAIN NERVE CELL; CALCIUM TRANSPORT; CEREBELLUM; CORPUS STRIATUM; CRYSTAL STRUCTURE; DEGENERATIVE DISEASE; DEPOLARIZATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; GENE MUTATION; GLOBUS PALLIDUS; HIPPOCAMPUS; HUMAN; HYDROLYSIS; LIPID DEGRADATION; LIPOGENESIS; MICROGLIA; NERVE ENDING; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PHARC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PUTAMEN; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE;

ANIMALS; ARACHIDONIC ACIDS; ENDOCANNABINOIDS; GLYCERIDES; HUMANS; MICE; MICROGLIA; MONOACYLGLYCEROL LIPASES; NEURONS; RECEPTORS, CANNABINOID; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 84855359304     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2011.02280.x     Document Type: Review

References (53)

1. Ahn, K., Johnson, D.S. & Cravatt, B.F. 2009. Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders. Expert Opin Drug Discov4, 763-784.
2. Alger, B.E. 2002. Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog Neurobiol68, 247-286.
3. Argaw, A., Duff, G., Zabouri, N., Cécyre, B., Chainé, N., Cherif, H., Tea, N., Lutz, B., Ptito, M. & Bouchard, J.F. 2011. Concerted action of CB1 cannabinoid receptor and deleted in colorectal cancer in axon guidance. J Neurosci31, 1489-1499.
4. Bertrand, T., Augé, F., Houtmann, J., Rak, A., Vallée, F., Mikol, V., Berne, P.F., Michot, N., Cheuret, D., Hoornaert, C. & Mathieu, M. 2010. Structural basis for human monoglyceride lipase inhibition. J Mol Biol396, 663-673.
5. Bisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M.G., Ligresti, A., Matias, I., Schiano-Moriello, A., Paul, P., Williams, E.J., Gangadharan, U., Hobbs, C., Di Marzo, V. & Doherty, P. 2003. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol163, 463-468.
6. Blankman, J.L., Simon, G.M. & Cravatt, B.F. 2007. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem Biol14, 1347-1356.
7. Cabral, G.A., Raborn, E.S., Griffin, L., Dennis, J. & Marciano-Cabral, F. 2008. CB2 receptors in the brain: role in central immune function. Br J Pharmacol153, 240-251.
8. Chanda, P.K., Gao, Y., Mark, L., Btesh, J., Strassle, B.W., Lu, P., Piesla, M.J., Zhang, M.Y., Bingham, B., Uveges, A. et al. 2010. Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system. Mol Pharmacol78, 996-1003.
9. De Petrocellis, L. & Di Marzo, V. 2009. Role of endocannabinoids and endovanilloids in Ca2+ signalling. Cell Calcium45, 611-624.
10. Di Marzo, V., Goparaju, S.K., Wang, L., Liu, J., Bátkai, S., Járai, Z., Fezza, F., Miura, G.I., Palmiter, R.D., Sugiura, T. & Kunos, G. 2001. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature410, 822-825.
11. Di Marzo, V., Bisogno, T. & De Petrocellis, L. 2007. Endocannabinoids and related compounds: walking back and forth between plant natural products and animal physiology. Chem Biol14, 741-756.
12. Dinh, T.P., Carpenter, D., Leslie, F.M., Freund, T.F., Katona, I., Sensi, S.L., Kathuria, S. & Piomelli, D. 2002. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA99, 10819-10824.
13. Dinh, T.P., Kathuria, S. & Piomelli, D. 2004. RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol. Mol Pharmacol66, 1260-1264.
14. Fiskerstrand, T., H'mida-Ben Brahim, D., Johansson, S., M'zahem, A., Haukanes, B.I., Drouot, N., Zimmermann, J., Cole, A.J., Vedeler, C., Bredrup, C. et al. 2010. Mutations in ABHD12 cause the neurodegenerative disease PHARC: an inborn error of endocannabinoid metabolism. Am J Hum Genet87, 410-417.
15. Freund, T.F., Katona, I. & Piomelli, D. 2003. Role of endogenous cannabinoids in synaptic signaling. Physiol Rev83, 1017-1066.
16. Gao, Y., Vasilyev, D.V., Goncalves, M.B., Howell, F.V., Hobbs, C., Reisenberg, M., Shen, R., Zhang, M.Y., Strassle, B.W., Lu, P. et al. 2010. Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. J Neurosci30, 2017-2024.
17. 2+ dependency for triggering retrograde endocannabinoid signal. Neuron45, 257-268.
18. Herkenham, M., Lynn, A.B., Johnson, M.R., Melvin, L.S., de Costa, B.R. & Rice, K.C. 1991. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci11, 563-583.
19. Hohmann, A.G. 2007. Inhibitors of monoacylglycerol lipase as novel analgesics. Br J Pharmacol150, 673-675.
20. Hurst, D.P., Grossfield, A., Lynch, D.L., Feller, S., Romo, T.D., Gawrisch, K., Pitman, M.C. & Reggio, P.H. 2010. A lipid pathway for ligand binding is necessary for a cannabinoid G protein-coupled receptor. J Biol Chem28, 17954-17964.
21. Jung, K.M., Astarita, G., Zhu, C., Wallace, M., Mackie, K. & Piomelli, D. 2007. A key role for diacylglycerol lipase-alpha in metabotropic glutamate receptor-dependent endocannabinoid mobilization. Mol Pharmacol72, 612-621.
22. Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M. & Watanabe, M. 2009. Endocannabinoid-mediated control of synaptic transmission. Physiol Rev89, 309-380.
23. Karlsson, M., Contreras, J.A., Hellman, U., Tornqvist, H. & Holm, C. 1997. cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases. J Biol Chem272, 27218-27223.
24. Katona, I., Urbán, G.M., Wallace, M., Ledent, C., Jung, K.M., Piomelli, D., Mackie, K. & Freund, T.F. 2006. Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci26, 5628-5637.
25. Keimpema, E., Barabas, K., Morozov, Y.M., Tortoriello, G., Torii, M., Cameron, G., Yanagawa, Y., Watanabe, M., Mackie, K. & Harkany, T. 2010. Differential subcellular recruitment of monoacylglycerol lipase generates spatial specificity of 2-arachidonoyl glycerol signaling during axonal pathfinding. J Neurosci30, 13992-14007.
26. Kinsey, S.G., Long, J.Z., O'Neal, S.T., Abdullah, R.A., Poklis, J.L., Boger, D.L., Cravatt, B.F. & Lichtman, A.H. 2009. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain. J Pharmacol Exp Ther330, 902-910.
27. Labar, G., Bauvois, C., Borel, F., Ferrer, J.L., Wouters, J. & Lambert, D.M. 2010a. Crystal structure of the human monoacylglycerol lipase, a key actor in endocannabinoid signaling. Chembiochem11, 218-227.
28. Labar, G., Wouters, J. & Lambert, D.M. 2010b. A review on the monoacylglycerol lipase: at the interface between fat and endocannabinoid signalling. Curr Med Chem17, 2588-2607.
29. i family of G proteins. Curr Neuropharmacol2, 191-206.
30. Lambert, D.M. & Fowler, C.J. 2005. The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications. J Med Chem48, 5059-5087.
31. Li, F., Fei, X., Xu, J. & Ji, C. 2009. An unannotated alpha/beta hydrolase superfamily member, ABHD6 differentially expressed among cancer cell lines. Mol Biol Rep36, 691-696.
32. Lichtman, A.H., Blankman, J.L. & Cravatt, B.F. 2010. Endocannabinoid overload. Mol Pharmacol78, 993-995.
33. Long, J.Z., Li, W., Booker, L., Burston, J.J., Kinsey, S.G., Schlosburg, J.E., Pavón, F.J., Serrano, A.M., Selley, D.E., Parsons, L.H., Lichtman, A.H. & Cravatt, B.F. 2009. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat Chem Biol5, 37-44.
34. Ludányi, A., Hu, S.S., Yamazaki, M., Tanimura, A., Piomelli, D., Watanabe, M., Kano, M., Sakimura, K., Maglóczky, Z., Mackie, K., Freund, T.F. & Katona, I. 2011. Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus. Neuroscience174, 50-63.
35. Mackie, K. 2006. Cannabinoid receptors as therapeutic targets. Annu Rev Pharmacol Toxicol46, 101-122.
36. Marrs, W.R., Blankman, J.L., Horne, E.A., Thomazeau, A., Lin, Y.H., Coy, J., Bodor, A.L., Muccioli, G.G., Hu, S.S., Woodruff, G. et al. 2010. The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors. Nat Neurosci13, 951-957.
37. Max, D., Hesse, M., Volkmer, I. & Staege, M.S. 2009. High expression of the evolutionarily conserved alpha/beta hydrolase domain containing 6 (ABHD6) in Ewing tumors. Cancer Sci100, 2383-2389.
38. Nomura, D.K., Long, J.Z., Niessen, S., Hoover, H.S., Ng, S.W. & Cravatt, B.F. 2010. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell140, 49-61.
39. 1 receptor activity in rat brain cryosections by functional autoradiography. J Neurochem101, 972-981.
40. Pan, B., Wang, W., Long, J.Z., Sun, D., Hillard, C.J., Cravatt, B.F. & Liu, Q.S. 2009. Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerollipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1, 3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) enhances retrograde endocannabinoid signaling. J Pharmacol Exp Ther331, 591-597.
41. Pertwee, R.G., Howlett, A.C., Abood, M.E., Alexander, S.P., Di Marzo, V., Elphick, M.R., Greasley, P.J., Hansen, H.S., Kunos, G., Mackie, K., Mechoulam, R. & Ross, R.A. 2010. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol Rev62, 588-631.
42. Petrosino, S. & Di Marzo, V. 2010. FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels. Curr Opin Investig Drugs11, 51-62.
43. Piomelli, D. 2003. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci4, 873-884.
44. Saario, S.M. & Laitinen, J.T. 2007. Therapeutic potential of endocannabinoid-hydrolyzing enzyme inhibitors. Basic Clin Pharmacol Toxicol101, 287-293.
45. Saario, S.M., Savinainen, J.R., Laitinen, J.T., Järvinen, T. & Niemi, R. 2004. Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. Biochem Pharmacol67, 1381-1387.
46. Saario, S.M., Salo, O.M., Nevalainen, T., Poso, A., Laitinen, J.T., Järvinen, T. & Niemi, R. 2005. Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes. Chem Biol12, 649-656.
47. Savinainen, J.R., Yoshino, M., Minkkilä, A., Nevalainen, T. & Laitinen, J.T. 2010. Characterization of binding properties of monoglyceride lipase inhibitors by a versatile fluorescence-based technique. Anal Biochem399, 132-134.
48. Schlosburg, J.E., Blankman, J.L., Long, J.Z., Nomura, D.K., Pan, B., Kinsey, S.G., Nguyen, P.T., Ramesh, D., Booker, L., Burston, J.J. et al. 2010. Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat Neurosci13, 1113-1119.
49. Straiker, A., Hu, S.S., Long, J.Z., Arnold, A., Wager-Miller, J., Cravatt, B.F. & Mackie, K. 2009. Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarization-induced suppression of excitation in autaptic hippocampal neurons. Mol Pharmacol76, 1220-1227.
50. Sugiura, T., Kishimoto, S., Oka, S. & Gokoh, M. 2006. Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Prog Lipid Res45, 405-446.
51. Tanimura, A., Yamazaki, M., Hashimotodani, Y., Uchigashima, M., Kawata, S., Abe, M., Kita, Y., Hashimoto, K., Shimizu, T., Watanabe, M., Sakimura, K. & Kano, M. 2010. The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission. Neuron65, 320-327.
52. Uchigashima, M., Narushima, M., Fukaya, M., Katona, I., Kano, M. & Watanabe, M. 2007. Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. J Neurosci27, 3663-3676.
53. Yoshida, T., Uchigashima, M., Yamasaki, M., Katona, I., Yamazaki, M., Sakimura, K., Kano, M., Yoshioka, M. & Watanabe, M. 2011. Unique inhibitory synapse with particularly rich endocannabinoid signaling machinery on pyramidal neurons in basal amygdaloid nucleus. Proc Natl Acad Sci USA108, 3059-3064.